EW vs NAMSW
Edwards Lifesciences Corp (EW) versus NewAmsterdam Pharma Company N.V. Warrant (NAMSW) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
NewAmsterdam Pharma Company N.V. Warrant (NAMSW) common stock listed on NASDAQ.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
NAMSW does not have a complete income-statement cache yet.
EW currently screens at market cap $49.91B and trailing P/E 46.9. NAMSW currently screens at market cap $0.
Not investment advice. Open the EW and NAMSW stock pages for the full models.
Not investment advice.